Co-Authors
This is a "connection" page, showing publications co-authored by Xing-Lou Yang and Ruiyuan Cao.
Connection Strength
0.165
-
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Virol Sin. 2020 Dec; 35(6):776-784.
Score: 0.056
-
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov. 2020; 6:28.
Score: 0.055
-
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
Score: 0.054